Bristol Myers (BMY) Squibb announced new five-year results from the POETYK PSO long-term extension trial of Sotyktu treatment in adult patients with moderate-to-severe plaque psoriasis. The safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback